Mynosys Welcomes Mediconsult as Zepto Distributor in Switzerland

March 15, 2019 - Posted in News
We are pleased to share the news that our partner in Switzerland for the distribution of our Zepto Personalized Cataract Surgery System is Mediconsult, headquartered in Roggwill, with a second office in ... [ read more ]

Visual Axis Centration JCRS Article Wins Highly Regarded Rosen Award

We are very excited to share the news that the JCRS May 2018 article by Dr. Vance Thompson has been conferred the prestigious 2018 Rosen Award. The Rosen Award is given “to the author(s) of the best technique article published in the year, as voted on by the editors.”

The winning article is titled “Streamlined method for anchoring cataract surgery and intraocular lens centration on the patient’s visual axis.”

It focuses on the “intraoperative method for the consistent anchoring of the intraocular lens (IOL) and cataract surgery and on the patient’s visual axis using coaxial microscope optics, surgeon-guided patient fixation, the precision pulse capsulotomy (PPC) device (Zepto) and utilizing the first (and fourth) Purkinje images.”

Here is the letter Dr. Thompson received announcing this highly regarded award. We look forward to the presentation ceremony with Dr. Thompson at ESCRS Congress on September 14-18, 2019 in Paris.

Zepto Thompson JCRS Rosen Award

Is it Possible to Decrease Capsular Fibrosis Using Zepto PCS?

CRST January 2019 Zepto Waltz PCOIn early 2016, Dr. Kevin Waltz participated in initial trials of the Zepto capsulotomy system (Mynosys) at Clínica Quesada in San Salvador, El Salvador. The Zepto device was subsequently approved by the FDA in June 2017 based on a successful US-based 510(k) device clinical trial.

When Dr. Waltz went back to El Salvador in late 2017 to follow up on the anterior capsulotomies created 1.5 years before, he found that they had been remarkably stable over time. But even more interesting were the posterior capsules in these eyes. There was little to no PCO at 1.5 years after surgery (Figure 2 in the article). Based on his 20 years of experience performing surgery in Central America, Dr. Waltz found this absence of PCO was a very unusual finding.

Dr. Waltz attributes these findings in part to the strong anterior capsulotomy that the Zepto creates, combined with the flushing mechanism to release the vacuum from the eye after the capsulotomy is created.

Read more in the January 2019 issue of Cataract and Refractive Surgery Today (CRST)